Author:
Iwakuma Yoshie,Kuroda Yukihiro
Reference27 articles.
1. Cationic amphiphilic drugs and phospholipid storage disorder;Kodavanti;Pharmacol Rev,1990
2. Bis(monoacylglycerol)phosphate as a non–invasive biomarker to monitor the onset and time–course of phospholipidosis with drug–induced toxicities;Tengstrand;Expert Opin Drug Metab Toxicol,2010
3. Drug–induced phospholipidosis confounds drug repurposing for SARS–CoV–2;Tummino;Science,2021
4. Phospholipidosis effect of drugs by adsorption into lipid monolayers;Ceccarelli;Colloids Surf B Biointerfaces,2015
5. Use of physicochemical calculation of pKa and ClogP to predict phospholipidosis–inducing potential: a case study with structurally related piperazines;Ploemen;Exp Toxicol Pathol,2004